Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laser.

Bourbonne V, Otz J, Bensadoun RJ, Dissaux G, Lucia F, Leclere JC, Pradier O, Schick U.

BMJ Support Palliat Care. 2019 Sep 16. pii: bmjspcare-2019-001851. doi: 10.1136/bmjspcare-2019-001851. [Epub ahead of print]

PMID:
31527154
2.

Oral Mucosal Injury Caused by Targeted Cancer Therapies.

Carrozzo M, Eriksen JG, Bensadoun RJ, Boers-Doets CB, Lalla RV, Peterson DE.

J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). pii: lgz012. doi: 10.1093/jncimonographs/lgz012.

PMID:
31425602
3.

Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.

Bouché O, Ben Abdelghani M, Labourey JL, Triby S, Bensadoun RJ, Jouary T, Des Guetz G.

World J Gastroenterol. 2019 Aug 7;25(29):4007-4018. doi: 10.3748/wjg.v25.i29.4007.

4.

Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.

Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3969-3983. doi: 10.1007/s00520-019-04890-2. Epub 2019 Jul 8.

PMID:
31286228
5.

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.

Legouté F, Bensadoun RJ, Seegers V, Pointreau Y, Caron D, Lang P, Prévost A, Martin L, Schick U, Morvant B, Capitain O, Calais G, Jadaud E.

Radiat Oncol. 2019 May 22;14(1):83. doi: 10.1186/s13014-019-1292-2.

6.

Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study.

Pflumio C, Troussier I, Sun XS, Salleron J, Petit C, Caubet M, Beddok A, Calugaru V, Servagi-Vernat S, Castelli J, Miroir J, Krengli M, Giraud P, Romano E, Khalifa J, Doré M, Blanchard N, Coutte A, Dupin C, Sumodhee S, Pointreau Y, Patel S, Rehailia-Blanchard A, Catteau L, Bensadoun RJ, Tao Y, Roth V, Geoffrois L, Faivre JC, Thariat J.

Eur J Cancer. 2019 Apr;111:69-81. doi: 10.1016/j.ejca.2019.01.004. Epub 2019 Feb 28.

PMID:
30826659
7.

Photobiomodulation or low-level laser therapy in the management of cancer therapy-induced mucositis, dermatitis and lymphedema.

Bensadoun RJ.

Curr Opin Oncol. 2018 Jul;30(4):226-232. doi: 10.1097/CCO.0000000000000452. Review.

PMID:
29794809
8.

Photobiomodulation therapy in the management of oral mucositis: search for the optimal clinical treatment parameters.

Elad S, Arany P, Bensadoun RJ, Epstein JB, Barasch A, Raber-Durlacher J.

Support Care Cancer. 2018 Oct;26(10):3319-3321. doi: 10.1007/s00520-018-4262-6. Epub 2018 May 22.

PMID:
29789949
9.

Management of radiation-induced mucosal necrosis with photobiomodulation therapy.

Epstein JB, Song P, Ho A, Larian B, Asher A, Bensadoun RJ.

Support Care Cancer. 2018 Aug;26(8):2493. doi: 10.1007/s00520-018-4228-8. Epub 2018 May 4. No abstract available.

PMID:
29728844
10.

Interest of Supportive and Barrier Protective Skin Care Products in the Daily Prevention and Treatment of Cutaneous Toxicity During Radiotherapy for Breast Cancer.

Berger A, Regueiro C, Hijal T, Pasquier D, De La Fuente C, Le Tinier F, Coche-Dequeant B, Lartigau E, Moyal D, Seité S, Bensadoun RJ.

Breast Cancer (Auckl). 2018 Jan 23;12:1178223417752772. doi: 10.1177/1178223417752772. eCollection 2018.

11.

Prevention and treatment of acute and chronic radiodermatitis.

Seité S, Bensadoun RJ, Mazer JM.

Breast Cancer (Dove Med Press). 2017 Nov 2;9:551-557. doi: 10.2147/BCTT.S149752. eCollection 2017.

12.

Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.

Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS.

Cancer Med. 2017 Dec;6(12):2918-2931. doi: 10.1002/cam4.1221. Epub 2017 Oct 25. Review.

13.

Photobiomodulation Therapy Alleviates Tissue Fibroses Associated with Chronic Graft-Versus-Host Disease: Two Case Reports and Putative Anti-Fibrotic Roles of TGF-β.

Epstein JB, Raber-Durlacher JE, Huysmans MC, Schoordijk MCE, Cheng JE, Bensadoun RJ, Arany PR.

Photomed Laser Surg. 2018 Feb;36(2):92-99. doi: 10.1089/pho.2017.4297. Epub 2017 Oct 19.

PMID:
29053051
14.

[Implementation of the tracer patient audit in a private radiation therapy centre].

Nardin S, Pinto N, Bensadoun RJ.

Cancer Radiother. 2017 Oct;21(6-7):662-664. doi: 10.1016/j.canrad.2017.07.031. Epub 2017 Sep 1. French.

PMID:
28870415
15.

Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.

Borchiellini D, Etienne-Grimaldi MC, Bensadoun RJ, Benezery K, Dassonville O, Poissonnet G, Llorca L, Ebran N, Formento P, Château Y, Thariat J, Milano G.

Oral Oncol. 2017 Apr;67:70-76. doi: 10.1016/j.oraloncology.2017.02.003. Epub 2017 Feb 14.

PMID:
28351583
16.

Supportive Care Organization in France: a national in-depth survey among patients and oncologists.

Scotté F, Hervé C, Leroy P, Tourani JM, Bensadoun RJ, Bugat ME, Farsi F, Jovenin N, Namer M, Tournigand C, Morin S, Brami C, Oudard S, Saadi A, Krakowski I.

Support Care Cancer. 2017 Jul;25(7):2111-2118. doi: 10.1007/s00520-017-3615-x. Epub 2017 Feb 20.

PMID:
28220314
17.

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group.

Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Erratum in: Lancet Infect Dis. 2017 Sep;17(9):897.

18.

Photobiomodulation therapy: management of mucosal necrosis of the oropharynx in previously treated head and neck cancer patients.

Epstein JB, Song PY, Ho AS, Larian B, Asher A, Bensadoun RJ.

Support Care Cancer. 2017 Apr;25(4):1031-1034. doi: 10.1007/s00520-016-3525-3. Epub 2016 Dec 17.

PMID:
27988865
19.

[Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].

Pointreau Y, Lizée T, Bensadoun RJ, Boisselier P, Racadot S, Thariat J, Graff P.

Cancer Radiother. 2016 Oct;20(6-7):445-51. doi: 10.1016/j.canrad.2016.07.066. Epub 2016 Sep 7. Review. French.

PMID:
27614524
20.

A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.

Balbous A, Cortes U, Guilloteau K, Rivet P, Pinel B, Duchesne M, Godet J, Boissonnade O, Wager M, Bensadoun RJ, Chomel JC, Karayan-Tapon L.

BMC Cancer. 2016 Aug 5;16:604. doi: 10.1186/s12885-016-2647-9.

21.

Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.

Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ.

Support Care Cancer. 2016 Jun;24(6):2793-805. doi: 10.1007/s00520-016-3153-y. Epub 2016 Mar 17. Review.

22.

Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.

Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ.

Support Care Cancer. 2016 Jun;24(6):2781-92. doi: 10.1007/s00520-016-3152-z. Epub 2016 Mar 16. Review.

23.

Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.

Meyers M, Granger B, Herman P, Janot F, Garrel R, Fakhry N, Poissonnet G, Baujat B; REFCOR members.

Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Feb;133(1):13-7. doi: 10.1016/j.anorl.2015.09.009. Epub 2015 Oct 20. Erratum in: Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Dec;133(6):453.

24.

Low-Level Laser Therapy in the Management of Mucositis and Dermatitis Induced by Cancer Therapy.

Bensadoun RJ, Nair RG.

Photomed Laser Surg. 2015 Oct;33(10):487-91. doi: 10.1089/pho.2015.4022. No abstract available.

PMID:
26447605
25.

Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.

Russi EG, Moretto F, Rampino M, Benasso M, Bacigalupo A, De Sanctis V, Numico G, Bossi P, Buglione M, Lombardo A, Airoldi M, Merlano MC, Licitra L, Denaro N, Pergolizzi S, Pinto C, Bensadoun RJ, Girolomoni G, Langendijk JA.

Crit Rev Oncol Hematol. 2015 Oct;96(1):167-82. doi: 10.1016/j.critrevonc.2015.06.001. Epub 2015 Jul 2. Review.

PMID:
26187236
26.

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J; ESMO Guidelines Committee.

Ann Oncol. 2015 Sep;26 Suppl 5:v139-51. doi: 10.1093/annonc/mdv202. Epub 2015 Jul 4. No abstract available.

PMID:
26142468
27.

Guidelines (short version) of the French Otorhinolaryngology - Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process.

Deneuve S, Babin E, Lacau-St-Guily J, Baujat B, Bensadoun RJ, Bozec A, Chevalier D, Choussy O, Cuny F, Fakhry N, Guigay J, Makeieff M, Merol JC, Mouawad F, Pavillet J, Rebiere C, Righini CA, Sostras MC, Tournaille M, Vergez S.

Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Sep;132(4):213-5. doi: 10.1016/j.anorl.2015.06.006. Epub 2015 Jun 29.

28.

[Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].

Troussier I, Huguet F, Servagi-Vernat S, Benahim C, Khalifa J, Darmon I, Ortholan C, Krebs L, Dejean C, Fenoglietto P, Vieillot S, Bensadoun RJ, Thariat J.

Cancer Radiother. 2015 Apr;19(2):127-38. doi: 10.1016/j.canrad.2014.12.005. Epub 2015 Mar 12. French.

PMID:
25770884
29.

A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.

Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME.

Support Care Cancer. 2015 Aug;23(8):2231-44. doi: 10.1007/s00520-014-2564-x. Epub 2015 Jan 7. Review.

30.

Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma.

Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L.

Mol Cancer Ther. 2014 Sep;13(9):2159-69. doi: 10.1158/1535-7163.MCT-13-1038. Epub 2014 Jul 22.

31.

[A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker].

Wislez M, Malka D, Bennouna J, Mortier L, Bensadoun RJ, Sicard J, Dielenseger P, Rey JB, Moro-Sibilot D, Scotté F.

Bull Cancer. 2014 Jun;101(6):647-52. doi: 10.1684/bdc.2014.1986. French.

PMID:
24977454
32.

[Nasopharyngeal cancers, an overview].

Jardel P, Thariat J, Blanchard P, Elloumi F, Toumi N, Bensadoun RJ, Frikha M, Daoud J, Bourhis J.

Bull Cancer. 2014 May 1;101(5):445-54. doi: 10.1684/bdc.2014.1964. Review. French.

PMID:
24886895
33.

Clinical nutrition guidelines of the French Speaking Society of Clinical Nutrition and Metabolism (SFNEP): Summary of recommendations for adults undergoing non-surgical anticancer treatment.

French Speaking Society of Clinical Nutrition and Metabolism (SFNEP).

Dig Liver Dis. 2014 Aug;46(8):667-74. doi: 10.1016/j.dld.2014.01.160. Epub 2014 May 1.

PMID:
24794790
34.

Cervical node of unknown primary: patterns of care and factors influencing the choice of clinical target volumes.

Troussier I, Bensadoun RJ, Chamorey E, Lapeyre M, Baujat B, Leysalle A, Sun XS, Pointreau Y, Calugaru V, Pan Q, Ovidiu V, Schultz P, Malard O, Bujor L, Morinière S, Chamois J, Coutte A, Michel X, Huguet F, Fouillet B, Roth V, Vernat SS, Meert N, Gallocher O, Drouet F, Lang P, Thariat J.

Oral Oncol. 2014 May;50(5):e25-6. doi: 10.1016/j.oraloncology.2014.02.010. Epub 2014 Mar 11. No abstract available.

PMID:
24630259
35.

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC, Bolla M, Marchal D, Van Laethem JL, Klein V, Giralt J, Clavère P, Glanzmann C, Cellier P, Collette L; EORTC Radiation Oncology Group.

Lancet Oncol. 2014 Feb;15(2):184-90. doi: 10.1016/S1470-2045(13)70599-0. Epub 2014 Jan 17.

PMID:
24440473
36.

[Radiation therapy for pleomorphic adenoma of the parotid].

Jardel P, Fakhry N, Makeieff M, Ferrie JC, Milin S, Righini C, Lacout A, Costes V, Malard O, Marcy PY, Guevara N, Odin G, Bensadoun RJ, Thariat J.

Cancer Radiother. 2014 Jan;18(1):68-76. doi: 10.1016/j.canrad.2013.09.007. Epub 2013 Dec 31. Review. French.

PMID:
24387927
37.

Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel.

Bensadoun RJ, Humbert P, Krutman J, Luger T, Triller R, Rougier A, Seite S, Dreno B.

Cancer Manag Res. 2013 Dec 9;5:401-8. doi: 10.2147/CMAR.S52256. eCollection 2013.

38.

[Advances in radiation oncology for metastatic bone disease].

Thariat J, Fric D, Kerr C, Leysalle A, Angellier G, Dejean C, Tuillier T, Bensadoun RJ, Lagrange JL.

Bull Cancer. 2013 Nov;100(11):1187-97. doi: 10.1684/bdc.2013.1849. Review. French.

PMID:
24172705
39.

[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC].

Thariat J, Jegoux F, Pointreau Y, Fayette J, Boisselier P, Blanchard P, Alfonsi M, Aupérin A, Bardet E, Bensadoun RJ, Garaud P, Geoffrois L, Graff P, Guigay J, Janot F, Lapeyre M, Lefebvre JL, Martin L, Racadot S, Rolland F, Sire C, Tao Y, Tuchais C, Chibaudel B, Girard-Calais MH, Cornely A, Vintonenko N, Calais G, De Raucourt D, Lacau Saint-Guily J, Bourhis J.

Bull Cancer. 2013 Oct;100(10):983-97. doi: 10.1684/bdc.2013.1829. Review. French.

PMID:
24126183
40.

[Target volumes in cervical lympadenopathies of unknown primary: toward a selective customized approach? On behalf of REFCOR].

Troussier I, Barry B, Baglin AC, Leysalle A, Janot F, Baujat B, Fakhry N, Sun XS, Marcy PY, Dufour X, Bensadoun RJ, Thariat J.

Cancer Radiother. 2013 Nov;17(7):686-94. doi: 10.1016/j.canrad.2013.07.132. Epub 2013 Oct 4. Review. French.

PMID:
24095636
41.

Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.

Wong RK, Bensadoun RJ, Boers-Doets CB, Bryce J, Chan A, Epstein JB, Eaby-Sandy B, Lacouture ME.

Support Care Cancer. 2013 Oct;21(10):2933-48. doi: 10.1007/s00520-013-1896-2. Epub 2013 Aug 14. Review.

PMID:
23942595
42.

Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.

Russi EG, Bensadoun RJ, Merlano MC, Bourhis J, Ricardi U, Giralt J, Pinto C, Budach W, Corvò R, Lacouture ME, Bernier J.

Ann Oncol. 2013 Sep;24(9):2463-5. doi: 10.1093/annonc/mdt281. Epub 2013 Jul 29. No abstract available.

PMID:
23897703
43.

[Cutaneous adverse reactions of EGFR (epidermal growth factor receptor)-inhibitors: therapeutic algorithm of the French PROCUR group].

Bachmeyer C, Reguiaï Z, Peuvrel L, Bachet JB, Bensadoun RJ, Ychou M, André T, Bouché O, Dréno B.

Bull Cancer. 2013 May;100(5):417-26. doi: 10.1684/bdc.2013.1735. Review. French.

PMID:
23694934
44.

Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology.

Dreno B, Bensadoun RJ, Humbert P, Krutmann J, Luger T, Triller R, Rougier A, Seité S.

J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1071-80. doi: 10.1111/jdv.12082. Epub 2013 Feb 1. Review.

45.
46.

Chemoradiation in anaplastic thyroid carcinomas.

Sun XS, Sun SR, Guevara N, Fakhry N, Marcy PY, Lassalle S, Peyrottes I, Bensadoun RJ, Lacout A, Santini J, Cals L, Bosset JF, Garden AS, Thariat J.

Crit Rev Oncol Hematol. 2013 Jun;86(3):290-301. doi: 10.1016/j.critrevonc.2012.10.006. Epub 2012 Dec 4. Review.

PMID:
23218594
47.

[Prostate cancer in elderly subjects: how diagnosis should be made, why and how geriatric assessment should be implemented].

Albrand G, Mottet N, Ruffion A, Fléchon A, Bensadoun RJ, Gigante M, Guy L, Mongiat-Artus P.

Prog Urol. 2012 Sep;22 Suppl 2:S55-63. doi: 10.1016/S1166-7087(12)70037-4. French.

PMID:
23098791
48.

Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.

Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E.

CA Cancer J Clin. 2012 Nov-Dec;62(6):400-22. doi: 10.3322/caac.21157. Epub 2012 Sep 12. Review.

49.

[Image-guided and adaptive radiotherapy].

Louvel G, Cazoulat G, Chajon E, Le Maître A, Simon A, Henry O, Bensadoun RJ, de Crevoisier R.

Cancer Radiother. 2012 Sep;16(5-6):423-9. doi: 10.1016/j.canrad.2012.07.177. Epub 2012 Aug 21. French.

PMID:
22920086
50.

Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02).

Thariat J, Bensadoun RJ, Etienne-Grimaldi MC, Grall D, Penault-Llorca F, Dassonville O, Bertucci F, Cayre A, De Raucourt D, Geoffrois L, Finetti P, Giraud P, Racadot S, Morinière S, Sudaka A, Van Obberghen-Schilling E, Milano G.

Clin Cancer Res. 2012 Sep 15;18(18):5123-33. Epub 2012 Aug 1.

Supplemental Content

Loading ...
Support Center